tbResList Print — NIV nivolumab
Filters:
qv=22, qv2=%, rfv=%
Product
NIV nivolumab
Features:
Immunomodulatory antibodies
Description:
<b>Two</b> different inhibitory pathways that block antitumor T cell responses. <br>
Pathway results for Effect on Cancer / Diseased Cells
Drug Metabolism & Resistance
ⓘ
Dose↝, 1
,
Functional Outcomes
ⓘ
OS↑, 1
,
Total Targets:
2
Pathway results for Effect on Normal Cells
Total Targets:
0
Research papers
Year
Title
Authors
PMID
Link
Flag
2025
Durable Response to Nivolumab Combined With Metformin in Advanced Pancreatic Cancer: A Case Report With Seven Years of Follow-Up.
Sato R
PMC11910964
https://europepmc.org/article/pmc/pmc11910964
0